|
FY2026
12 months to May 31, 2026
|
FY2025
12 months to May 31, 2025
|
FY2024
12 months to May 31, 2024
|
FY2023
12 months to May 31, 2023
|
FY2022
12 months to May 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows used in operating activities | |||||
| Net income (loss) | |||||
| Accrued interest on notes payable | |||||
| Accrued interest on vendor payable | |||||
| Gain (loss) on forgiveness of debt | |||||
| Non-cash investor relations fees | |||||
| Unrealized foreign exchange | |||||
| Other current assets: | |||||
| Accounts payable: | |||||
| Accrued liabilities: | |||||
| Due to related parties: | |||||
| Net cash flows used in operating activities | |||||
| Net Cash Flows from Financing Activities | |||||
| Proceeds from related party notes | |||||
| Notes payables, proceeds | |||||
| Proceeds from sale of shares | |||||
| Net cash provided by financing activities | |||||
| Effects of foreign currency exchange on cash | |||||
| Decrease in cash | |||||
| Cash, beginning | |||||
| Cash, ending | |||||
Loading...